Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 2—February 2020

Chronic Human Pegivirus 2 without Hepatitis C Virus Co-infection

Kelly E. CollerComments to Author , Veronica Bruce, Michael Cassidy, Jeffrey Gersch, Matthew B. Frankel, Ana Vallari, Gavin Cloherty, John Hackett, Jennifer L. Evans, Kimberly Page, and George J. Dawson
Author affiliations: Abbott Laboratories, Abbott Park, Illinois, USA (K.E. Coller, M. Cassidy, J. Gersch, M.B. Frankel, A. Vallari, G. Cloherty, J. Hackett, Jr., G.J. Dawson); University of New Mexico, Albuquerque, New Mexico, USA (V. Bruce, K. Page); University of California San Francisco, San Francisco, California, USA (J.L. Evans)

Main Article

Table 2

Evidence of HPgV-2 infection in most recent samples from study of chronic HPgV-2 infection and HCV co-infection in injection drug users in the San Francisco Bay area, California, USA*

HCV RNA status at initial draw Sample ID HPgV-2 status at initial blood draw
HPgV-2 status at last blood draw
HCV RNA status No. days† Comments‡
RNA Antibody RNA Antibody
Negative QM0003 Pos Neg Pos Pos Neg 832 Chronic
VH0052 Pos Pos Neg Pos Neg 201 Resolved
VP0295 Neg Neg Pos Pos Neg 553 Active
GG0012 Neg Neg Neg Pos Neg 689 Resolved
RM0095 Neg Neg Neg Pos Neg 201 Resolved
RM0337§ Neg Neg Neg Pos Pos 1,680 Resolved
VH0044 Neg Pos Neg Neg Neg 250 Resolved
Positive VH0085 Pos Pos Pos Pos Neg 2,805 Chronic
GG0038 Neg Neg Pos Neg Neg 461 Active
VT0031 Neg Neg Pos Pos Pos 818 Active

*HCV, hepatitis C virus; HPgV-2, human pegivirus 2; neg, negative; pos, positive.
†Days elapsed between initial and last blood draw.
‡Comments of HPgV-2 status based on initial and last draw testing. Chronic indicates >6 months with detectable active viremia. Active indicates viremia at last draw. Resolved indicates no viremia detected at last draw, but antibodies were present.
§Participant RM0337 acquired HCV during the study.

Main Article

Page created: January 17, 2020
Page updated: January 17, 2020
Page reviewed: January 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.